Table 4.
Multivariable logistic regression of compliance with recommendation about chemotherapy.
| Independent variables | Level | Dependent variables | |||||
|---|---|---|---|---|---|---|---|
| Low-risk patients | Intermediate-risk patients | High-risk patients | |||||
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | ||
| Hospital level | Tertiary | 1.93 (0.08, 45.97) | 0.684 | 0.38 (0.13, 1.11) | 0.077 | 1.80 (0.63, 5.15) | 0.272 |
| Secondary and below | Reference | ||||||
| Years of practice | 11~20 | 0.24 (0.03, 2.21) | 0.207 | 1.77 (0.54, 5.86) | 0.348 | 0.46 (0.16, 1.33) | 0.15 |
| 21~30 | 0.22 (0.02, 3.20) | 0.271 | 0.87 (0.18, 4.23) | 0.86 | 1.24 (0.29, 5.38) | 0.773 | |
| ≥31 | 0.20 (0.01, 4.52) | 0.31 | 0.51 (0.07, 3.58) | 0.496 | 1.07 (0.18, 6.51) | 0.942 | |
| ≤10 | Reference | ||||||
| Education background | PhD | 4.42 (0.37, 52.56) | 0.239 | 5.76 (1.30, 25.49) | 0.021 | 2.48 (0.67, 9.16) | 0.174 |
| Master | 6.11 (0.65, 57.62) | 0.114 | 1.23 (0.47, 3.21) | 0.674 | 0.94 (0.36, 2.44) | 0.901 | |
| Bachelor or college | Reference | ||||||
| Professional title | Senior | 3.39 (0.25, 46.34) | 0.361 | 3.25 (0.61, 17.31) | 0.167 | 2.33 (0.53, 10.23) | 0.263 |
| Vice-senior | 0.71 (0.09, 5.50) | 0.744 | 1.28 (0.41, 4.04) | 0.671 | 2.91 (0.98, 8.62) | 0.054 | |
| Middle and below | Reference | ||||||
| Having participated in guideline development | Yes | 0.61 (0.11, 3.32) | 0.566 | 0.15 (0.05, 0.47) | 0.001 | 0.62 (0.16, 2.49) | 0.503 |
| No | Reference | ||||||
| Region | The Middle | 1.12 (0.22, 5.60) | 0.894 | 0.24 (0.07, 0.89) | 0.033 | 1.14 (0.38, 3.47) | 0.816 |
| The West | 1.96 (0.48, 7.96) | 0.347 | 0.39 (0.10, 1.46) | 0.164 | 0.66 (0.22, 2.01) | 0.464 | |
| The East and the Northeast | Reference | ||||||
| Number of guidelines consulted | 1.12 (0.75, 1.68) | 0.573 | 1.32 (1.00, 1.74) | 0.047 | 0.79 (0.60, 1.05) | 0.099 | |
| Knowledge of this recommendation | 57.71 (16.77, 198.60) | <0.001 | 101.59 (44.85, 230.12) | <0.001 | 254.97 (104.95, 619.46) | <0.001 | |